More NewsRead More
BioTime Co-CEO Dr. Michael West to Present at Stem Cells in Drug Discovery 2016 in Cambridge, UK
April 05, 2016
BioTime, Inc. to Host Conference Call to Update Investors on Recent Accomplishments and Corporate Objectives for 2016
March 21, 2016
Asterias Biotherapeutics Appoints Stephen L. Cartt President and Chief Executive Officer
February 29, 2016
from PR Newswire
BioTime Subsidiary Asterias Biotherapeutics Reports the Successful End-of-Phase II FDA Meeting for Immunotherapy in Acute Myeloid Leukemia
February 24, 2016
BioTime, Inc. to Present at Three Investor Conferences in February
February 01, 2016
Adjustments Affecting BioTime, Inc. Common Share Purchase Warrants Expiring October 1, 2018
January 12, 2016
BioTime and Asterias Sign Share Transfer Agreement and Cross-License Agreement for Pluripotent Stem Cell Related Patents
February 16, 2016
Stock Market XML and JSON Data API provided by FinancialContent Services, Inc.
Nasdaq quotes delayed at least 15 minutes, all others at least 20 minutes.
Markets are closed on certain holidays. Stock Market Holiday List
By accessing this page, you agree to the following
Press Release Service provided by PRConnect.
Stock quotes supplied by Six Financial
Postage Rates Bots go here